Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: LarryS who wrote (7233)	9/13/1998 8:16:00 AM
From: Robert K.	Read Replies (1) \| Respond to of 17367

While we wait away cnbc and dsmb (could be anytime now).......>>> >>Here is a article in support of cystic fibrosis trial and the trauma trial (remember the LUNG is the focus) Just think ......would bpi help? Above is IMO, Below is from medline. Here it is>>>> start> J Surg Res 1998 Jul 15;78(1):42-47 Pulmonary LPS-Binding Protein (LBP) Upregulation Following LPS-Mediated Injury. Klein RD, Su GL, Aminlari A, Alarcon WH, Wang SC Department of Surgery Background. The acute respiratory distress syndrome (ARDS) causes significant morbidity and mortality among trauma patients. Although multiple factors have been implicated, pulmonary injury in this population may be due to inflammatory mediators released in response to stimuli such as endotoxin (LPS). LBP plays an integral part in LPS-mediated release of inflammatory cytokines and increased local expression of LBP as the result of a primary injury may prime the lung to secondary LPS-mediated damage. Materials and methods. To determine the magnitude of pulmonary LBP upregulation following LPS injury we challenged rats with either intravenous (IV) or intratracheal (IT) LPS. Animals from each group were euthanized at 1, 2, 4, and 8 h postchallenge. Lung LBP and CD14 mRNA levels were assayed by Northern blot. Serum and bronchoalveolar lavage (BAL) fluid were assayed for inflammatory cytokines (TNF-alpha, MCP-1, IL-1beta, IL-6, and IL-10) by ELISA. Results. LBP and CD14 mRNA levels were found to increase significantly in lung tissue after both IV and IT LPS with the IV LPS animals having a greater increase over 8 h. Serum TNF-alpha was significantly elevated in the IV LPS group whereas very low levels were detected in the BAL. Only BAL TNF-alpha was increased in the IT group at 8 h. Conclusion. Local pulmonary LBP and CD14 mRNA are both upregulated after either systemic or local LPS exposure. Such upregulation may render thelung more susceptible to local immune overactivation and injury during subsequent exposures to LPS. Copyright 1998 Academic Press.

To: LarryS who wrote (7233)	9/13/1998 2:55:00 PM
From: Robert K.	Respond to of 17367

18 Job offerings on biosite. Eighteen. Hmmmmm...........................>>> >> Associate Scientist In Biochemistry Associate Scientist In Pharmaceutical Development Clinical Research Associate II General Accounting Specialist Manager Of Analytical Biochemistry Manager Of Clinical Operations Postdoctoral Fellow In Bioprocess Development Postdoctoral In Cell Biology Programmer Analyst II/III QA Associate II QC Associate III Quality Engineering Specialist Receptionist Regulatory Affairs Associate II Scientist I In Pharmaceutical Development Senior Clinical Research Associate I Senior Regulatory Affairs Associate Supervisor Of Operations